[Next-Generation Sequencing Book]
  • [Photo] David Lapointe • October 17, 2000
    Biotechnology and IT are increasingly synthesizing in the accelerated push to map the human genome. Biotech research is demanding greater database capacity and processing power, opening up new markets for IT. Although other high-tech players such as 3M, Agilent, Compaq, Intel, and Motorola are launching biotech ventures, IBM led the fray when it announced its five-year initiative to develop a powerful new biotech supercomputer. IBM has already built the world's fastest supercomputer, ASCI White, but the company is now developing Blue Gene to be 100 times more powerful than the current model in order to unravel the complexities of proteins. Interest in biochips and other IT contributions has mounted because researchers believe that understanding genes and pinpointing their role in disease is central to drug discovery and treatment.

    Full story:
    http://www.sfgate.com/cgi-bin/article.cgi?file=/chronicle/archive/2000/10/09/BU113958.DTL

Discussion forums: SF Gate: Tech Giants Jumping into BioTech

Expanded view | Monitor forum | Save place

Start a new thread:

You have to be logged in to post a reply.

© 1998-2025 Scilico, LLC. All rights reserved.